Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.20.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current assets    
Cash and cash equivalents $ 272,092 $ 293,484
Short-term deposits 27,000 28,300
Accounts receivable, net of allowance for credit losses of $0.9 million as of December 31, 2020 and December 31, 2019 106,068 132,558
Inventories 131,672 168,504
Prepaid expenses 6,717 6,567
Other current assets 16,943 29,659
Total current assets 560,492 659,072
Non-current assets    
Property, plant and equipment, net 201,232 189,706
Goodwill 35,694 385,658
Other intangible assets, net 131,569 87,328
Operating lease right-of-use assets 21,298 20,936
Other non-current assets 39,717 38,819
Total non-current assets 429,510 722,447
Total assets 990,002 1,381,519
Current liabilities    
Accounts payable 16,987 35,818
Accrued expenses and other current liabilities 31,061 28,528
Accrued compensation and related benefits 25,659 34,013
Deferred revenues - short-term 49,165 52,268
Operating lease liabilities - short term 9,282 9,292
Total current liabilities 132,154 159,919
Non-current liabilities    
Deferred revenues - long-term 14,227 16,039
Operating lease liabilities - long term 12,567 12,445
Contingent consideration 37,400  
Other non-current liabilities 34,059 35,343
Total non-current liabilities 98,253 63,827
Total liabilities 230,407 223,746
Commitments and contingencies (see note 10)
Redeemable non-controlling interests 227 622
Equity    
Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousands shares; 56,617 thousand shares and 54,441 thousand shares issued and outstanding at December 31, 2020 and 2019, respectively 155 148
Additional paid-in capital 2,753,955 2,706,894
Accumulated other comprehensive loss (8,846) (7,716)
Accumulated deficit (1,985,896) (1,542,175)
Total equity 759,368 1,157,151
Total liabilities and equity $ 990,002 $ 1,381,519